Proteins associated with familial neurodegenerative disease often aggregate in patients' neurons.
Introduction
Mutations in an increasing number of human genes have been found to cause familial neurodegenerative disease [1, 2] . Proteins encoded by these genes are often soluble in healthy individuals, but form insoluble amyloid-like aggregates that seed further aggregation in the neurons of patients with disease. For example, such conformational changes have been seen for: A, associated with Alzheimer's disease; -synuclein with Parkinson's disease; TDP-43, FUS and others with amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD); and huntingtin with Huntington's disease. Wild-type and mutant forms of these proteins are respectively associated with aggregates in sporadic and familial forms of the diseases. Overexpression of either wild-type or mutant protein causes toxicity, although the mutant forms are often toxic at lower concentrations than the wildtype [3] .
Conformational change of several yeast proteins from a soluble state to insoluble self-seeding aggregates, called prions, causes transmissible phenotypic changes [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . Furthermore, the presence of one prion aggregate enhances the de novo appearance of heterologous prions. For example, the endogenous yeast prion [PIN + ], which is an amyloid form of the RNQ1 protein, promotes the de novo aggregation of the SUP35 protein to form the [PSI + ] prion. This could occur by cross-seeding or by sequestration of proteins such as chaperones by the amyloid [PIN + ] prion [8, [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] .
Yeast has proved to be useful in the study of disease-specific proteins that form prion-like aggregates [28] [29] [30] [31] [32] [33] [34] [35] . When human proteins associated with aggregation in neurodegenerative disease were expressed in yeast, they formed aggregates and caused toxicity. Curiously the toxicity of several of these proteins, e.g. TDP-43, FUS or huntingtin, is enhanced by the presence of the [PIN + ] prion [28, 36, 37] . These yeast models have allowed the identification of yeast genes that either alter the disease protein's aggregation or enhance or reduce its toxicity. Remarkably, human homologs of these yeast modifier genes have confirmed (PICALM for Alzheimer's [38] [39] [40] , PARK9 for Parkinson [38, 41] ), and identified new (ATXN2 [42] [43] [44] [45] [46] for ALS and XPO1, ADSSL1 and RABGEF1 for Alzheimer's [38, 40] ), human risk factors for the modeled disease. Indeed, the discovery in yeast that deletion of the ATXN2 (Ataxin-2) ortholog, PBP1, reduced TDP-43 toxicity, led to the recent exciting finding that reduction in ATXN2 levels dramatically lowers neurotoxicity in ALS mouse models [43] . Thus the establishment of new yeast neurodegenerative disease models may lead to the identification of new risk factors for human disease as well as provide a screening platform for drug discovery.
Recently, mutations in SS18L1 have been shown to cause ALS [47, 48] . SS18L1 encodes the calcium-responsive transactivator (CREST) protein which is an essential component of the nBAF neuron-specific chromatin remodeling complex that is related to the yeast SWI/SNF chromatin remodeling complex [49] [50] [51] . Overexpression of CREST inhibits neurite outgrowth in cultured neurons and causes retina degeneration in transgenic Drosophila [48, 52] . Also, CREST co-immunoprecipitates with FUS in neuron lysates [48, 52] . In cultured cells, transformed CREST forms predominantly nuclear dots with some cytoplasmic foci. Also, like other ALS associated proteins, CREST is recruited to stressinduced ribonucleoprotein particle (RNP) granules [52, 53] . RNP proteins must reversibly aggregate in physiological granules as part of their normal cellular function, but this ability to aggregate could lead to the formation of pathological aggregates. Indeed, TDP-43 and FUS have prion-like domains and have been found in cytoplasmic aggregates in the neurons of patients with ALS. While no such patient aggregates have yet been reported for CREST, it has an unstructured prion-like domain predicted to form amyloid-like aggregates [48] . CREST in cell culture was slightly resistant to Triton-X100 but was solubilized by SDS; in addition it formed nuclear dots in a concentration-dependent manner [52] .
Here we establish a new ALS model in yeast. We show that this human chromatin remodeling complex component and transcriptional activator is toxic and forms largely nuclear aggregates that stain with an amyloid dye when expressed in yeast. We also show that CREST toxicity is increased by the endogenous yeast [PIN + ] prion. Furthermore, like SWI1 [54] , CREST inhibits telomeric and epigenetic silencing of FLO genes thereby enhancing flocculation (cell clumping). Deletion of the TDP-43 toxicity modifier, PBP1, likewise reduces CREST toxicity and this finding was also confirmed in a CREST transgenic fly model. Finally, overexpression of PBP1, causes a large portion of CREST to leave the nucleus and co-localize with PBP1-GFP containing cytoplasmic granules.
Results

Expression of human CREST in yeast is toxic.
Growth of yeast transformed with control GAL-GFP vectors was compared with yeast expressing fusions of human CREST cDNA and GFP from a GAL promoter on three types of vectors: a Yeast CEN plasmid (YCp) containing a centromere and expressed as one or a few copies in each cell (Fig. 1a ); a Yeast Episomal plasmid (Yep) containing elements of the endogenous yeast 2 episome and expressed in high copy in some cells but absent in other cells (Fig. 1b) ; or a Yeast Integrating plasmid (YIp) that was integrated into the genome (Fig. 1c ). Expression of the GAL controlled genes was turned on with a constitutively expressed fusion of the human estrogen receptor hormone-binding domain, the yeast GAL4 DNA-binding domain and the VP16 viral transcriptional activator, which was activated by the addition of -estradiol [55] . The high level of -estradiol used here (1M) in glucose media results in more expression from the GAL promoter than that obtained by traditional induction on 2% galactose without -estradiol [56] . Growth inhibition is evident but slight when CREST-GFP was expressed from a CEN vector ( Fig. 1a ) and more inhibition is seen when episomal ( Fig. 1b ) or integrating vectors ( Fig. 1c) were used.
Since the presence of the [PIN + ] prion causes enhanced toxicity of the human genes huntingtin/polyQ, TDP-43 and FUS [28, 36, 37, 57] , we asked if [PIN + ] would likewise increase toxicity of CREST and found that it did ( Fig. 2a ). However, CREST and [PIN + ] aggregates did not co-localize ( Fig.   2b ). Also, CREST aggregated in both [PIN + ] and [pin -] cells (Figs 2b and 2c) and was toxic ( Fig. 2d ) even in cells lacking the HSP104 chaperone required for the propagation of many yeast prions [4, 58] .
Note the reduced induction of CREST caused by galactose relative to -estradiol results in reduced toxicity.
Expression of human CREST activates yeast FLO genes and causes flocculation.
While working with GAL-CREST-GFP and GAL-GFP transformants we noticed that expression of CREST-GFP caused cells in liquid culture to settle very rapidly compared to the GFP controls. In a measured experiment we found that overexpression of CREST caused flocculation (cell clumping), while overexpression of TDP-43 or FUS did not ( Fig. 3a ).
Since CREST increased yeast flocculence just as the non-prion form of the SWI1 chromatin remodeling protein does [54] , we hypothesized that CREST, like SWI1, remodels yeast chromatin structure causing a release of silencing of telomerically located and epigenetically controlled [59] FLO genes, resulting in flocculation. To test this we examined the effect of CREST on the telomerically located FLO1 and the epigenetically controlled FLO11 promoters, using ura3Δ strains with either the FLO1 or FLO11 open reading frames (ORFs) replaced with the URA3 ORF reporter [54] . In the absence of CREST these strains were auxotrophic for uracil indicating that both the FLO1 and FLO11 promoters were off. However, upon CREST expression on galactose medium, both strains gained the ability to grow in the absence of uracil, indicating that the FLO1 and FLO11 promoters were indeed both activated by CREST ( Fig. 3b ).
CREST forms largely nuclear and occasionally cytoplasmic amyloid foci.
Similar to mammalian cells [52] , CREST-GFP expressed in either [PIN + ] or [pin -] yeast was localized to nuclear dots (Figs 4a and 5a). CREST-GFP dots were largely clustered in nuclei but smaller cytoplasmic foci were also visible especially after longer induction times ( Fig. 4a ). Nuclear localization was confirmed by using a constitutively expressed nuclear HTB1-mCh marker (Figs 4b and Supplementary Fig. S1 ) which co-localized with CREST-GFP. CREST foci also stained with the amyloid dye thioflavin T ( Fig. 4c ). For controls we show TDP-43 and FUS aggregates that, respectively do not and do, stain with thioflavin T [60] . In addition, the bulk of the CREST protein is found in the pellet of lysates while the non-aggregated proteins, GFP and PGK, remain in the supernatant (Fig. 4d ).
When CREST was overexpressed in mammalian cells, it formed large dot-like nuclear structures and was also present in cytoplasmic aggregates [52] . When CREST is expressed in yeast for 5-6 h, most of the protein is found in nuclear dots with just occasional cytoplasmic foci (see Fig. 4 and Fig. 5 left) . However, when cells with nuclear CREST are stressed by incubation at high temperature there is a dramatic increase in the appearance of cytoplasmic foci ( Fig. 5 middle) that partially co-localize with Ded1-mCh stress granule and EDC3-mCh P-body markers. Following a return to 30°C, cytoplasmic CREST aggregates disappear along with stress granules and P-bodies ( Fig. 5 right) .
Unlike [PIN + ] aggregates, CREST dots and foci do not seed SUP35 prion formation.
Considerable evidence suggests that amyloid-like aggregates of one protein can facilitate the de novo We found that unlike [PIN + ], or overexpression of a variety of QN-rich yeast proteins [8] , overexpression of CREST did not cause the appearance of fluorescent SUP35NM-GFP rings or of adenine prototrophy. This was true even when PBP1 was also overexpressed to drive CREST-dsRED aggregates into the cytoplasm ( Supplementary Fig. S2 ).
PBP1 affects the aggregation and toxicity of CREST in yeast and flies.
Overexpression of yeast's PBP1, a homolog of human ATXN2, enhances, while PBP1 deletion reduces, the toxicity of TDP-43 expressed in yeast [42] . This led to the discovery that ATXN2 intermediate-length polyglutamine expansions, which are associated with increased ATXN2 protein levels, are a risk factor for ALS [42] . Work in a variety of model organisms including mice, now suggests that ATXN2 is a modifier of some neurodegenerative diseases [43] .
We thus tested the effect of PBP1 level on the aggregation and toxicity of CREST in yeast. We found a dramatic increase in cytoplasmic CREST dots when PBP1 was overexpressed Fig. 6a . This was not due to an increase in CREST protein level ( Fig. 6b ). We also found the CREST-DsRed dots co-localized with PBP1-GFP cytoplasmic granules ( Fig. 6c ). Overexpression of PBP1 itself was toxic in our system ( Fig. 6d ) so the effect on CREST toxicity could not be determined.
However, we clearly show that deletion of PBP1 reduced toxicity in either a [PIN + ] or [pin -] background ( Fig. 6e ). This was not due to either a reduced level of CREST or an increase in its solubility (Figs 6b and 4d). Also, we did not detect any effect of pbp1Δ on the microscopically observed cellular location of CREST-GFP.
In order to validate the observed effect of the ATXN2 homolog PBP1 in an independent in vivo model, we used transgenic Drosophila which possesses an ortholog of the human ATXN2 gene, dAtx2.
Overexpression of untagged CREST using GAL4-UAS system in Drosophila lines results in severe retinal degeneration [52] . For our studies, we used dAtx2 deletion fly line (dAtx2 06490) [61] .
Homozygous deletion of dAtx2 was reported to cause disorganized and decreased photoreceptor neurons, but there was no effect in the heterozygous state [61] . We crossed CREST overexpressing (transgenic, TG) flies with heterozygous dAtx2 flies (dAtx2 06490 /+ ) and analyzed the double TG progeny.
Histological analysis confirmed normal retinal morphology in of dAtx2 06490 /+ flies, whereas complete disruption of the regularly ordered arrays of photoreceptor neurons was observed in the retina in CRESTwt TG flies, consistent with the previous reports ( Fig. 7) . Strikingly, this severe retinal degenerative phenotype in CRESTwt TG flies was almost entirely rescued by downregulation of dAtx2 (CRESTwt TG; dAtx2 06490 /+ line) ( Fig. 7) . Thus, human CREST toxicity in flies is largely mediated by endogenous dAtx2.
Discussion
Our data show that human CREST expressed in yeast shares properties with other ALS associated proteins: CREST and FUS form amyloid foci; CREST, TDP-43 and FUS toxicity is enhanced by the yeast prion [PIN + ]; TDP-43 and CREST toxicity is reduced by deletion of PBP1; CREST, TDP-43 and FUS are associated with cytoplasmic RNP granules.
We first described [PIN + ], the prion form of the RNQ1 protein, because its presence allowed the efficient conversion of the SUP35 protein to its prion form, [PSI + ] [8, 17, 63] . It was later shown that [PIN + ] is also required for the efficient aggregation and toxicity of polyQ in yeast [28] . The mechanisms causing these effects are still unknown. Some data support the hypothesis that the [PIN + ] aggregates of RNQ1 cross-seed aggregation of heterologous proteins such as SUP35 and polyQ. Likewise some, but not all evidence suggests that the [PIN + ] aggregates bind proteins such as chaperones that would otherwise inhibit aggregation of the heterologous SUP35 or polyQ protein, thereby enhancing their aggregation [18] [19] [20] [21] [22] [23] [24] [25] 27] We recently showed that toxicity of TDP-43 and FUS is enhanced by the presence of [PIN + ] [37, 57] . Both of these proteins contain Q/N-rich regions and co-aggregate with polyQ disease protein alleles of huntingtin [64, 65] . Surprisingly, we did not Prion aggregates enhance de novo formation of heterologous prion, presumably by a crossseeding mechanism. Curiously, however, if heterologous prion is already present, prion aggregates instead promote loss of the heterologous prion [20] . One mechanism for this has been shown to be prion aggregate binding to, and therefore titration of, chaperones needed to propagate the heterologous prion [24] . Likewise, CREST has been shown to suppress polyQ-mediated huntingtin aggregation and toxicity [67] .
Many of the ALS associated proteins, e.g. TDP-43, FUS and TAF15 are soluble nuclear RNA/DNA binding proteins that regulate mRNA splicing and/or stability and contain prion-like unstructured domains and nuclear/cytoplasmic trafficking signals. In neurons of patients with ALS/FTD these proteins have been found in cytoplasmic aggregates instead of their normal nuclear location. This suggests that impaired nucleocytoplasmic transport may be a general mechanism for neurotoxicity [3, [68] [69] [70] [71] [72] [73] . Indeed, impairing nuclear import of TDP-43 enhances neurotoxicity [74] .
While TDP-43 and FUS quickly form cytoplasmic aggregates in yeast with little or no nuclear localization [31, 32, 37, 57, [75] [76] [77] , we found here that CREST appeared in nuclear aggregates with only occasional cytoplasmic foci. While the ALS associated proteins TDP-43, FUS and SOD1 form aggregates in patients, model systems and in vitro, these aggregates are sometime but not always classical amyloids. In yeast, FUS, but not TDP-43, aggregates stain with the amyloid dye thioflavin T [60] . Although both nuclear and cytoplasmic CREST foci appear to stain with thioflavin T and therefore contain amyloid, it is still tempting to speculate, by analogy with FUS and TDP-43, that the CREST cytoplasmic foci are more toxic than nuclear CREST. It is unknown if similar aggregates form in patients and associated with neuronal death.
We found that heat stress induced CREST to leave the nucleus and partially co-localize with RNP granules. This is consistent with previous findings in mammalian cells that CREST becomes mislocalized to the cytoplasm under stressful conditions (oxidative stress) and becomes recruited to cytoplasmic stress granules [52] . Furthermore, as seen for classic stress granule proteins, CREST returned to the nucleus in yeast following the heat stress. Many proteins associated with neurodegenerative disease contain intrinsically disordered regions that are required for their appearance in RNP granules. Evidence has been accumulating that RNP granules are incubators for the formation of pathogenic protein aggregates associated with neurodegenerative disease. It has been proposed that localization of proteins such as TDP-43, FUS and C9OFR72-encoded dipeptide repeat GR50 in high concentration in stress granules likely in a gel form, promotes their conversion into pathogenic amyloid-like aggregates [78] [79] [80] [81] [82] .
In support of this model, RNP-granule formation has been shown to be strongly associated with neurodegeneration. This was accomplished with the aid of ATXN2, an RNP-protein that is required for RNP-granule formation. Three ALS associated proteins, TDP-43, FUS and C9OFR72-encoded dipeptide repeat GR50, have been shown to co-localize with ATXN2 RNP granules [42, 78] in yeast, human or Drosophila S2 cells. Also, either reducing the level of ATXN2 or deleting one of its intrinsically disordered regions both reduced RNP-granule formation and reduced neurodegeneration caused by TDP-43, C9ORF72 dipeptide or FUS [78, [83] [84] [85] . These results help explain why expansions of the polyQ regions in ATXN2 that increase the stability, and thus likely the level of ATXN2, are associated with neurodegenerative disease (susceptibility to ALS and type 2 spinocerebellar ataxia).
Here, using a yeast model system we report similar effects of PBP1, the yeast ATXN2 homolog, on CREST: overexpression of PBP1 causes CREST to co-localize with PBP1 in cytoplasmic granules; deletion of PBP1 reduces toxicity of CREST. Overexpression of PBP1 has previously been shown to induce the formation of cytoplasmic PBP1 foci [86] that recruit TORC1 thereby downregulating TORC1 function [87] . PBP1 foci may similarly attract CREST to cytoplasmic granules which may promote CREST's conversion to a more toxic form. Consistently, in a transgenic Drosophila model of CREST proteinopathy, deletion of the fly ATXN2 ortholog, dAtx2, dramatically mitigated CREST toxicity in retinal ganglion cells. Therefore, we showed that CREST is yet another protein, in addition to TDP-43, that is highly sensitive to ATXN2 dosage indicating that ATXN2 likely has a more general role as a modifier of neurotoxicity.
In mammals, endogenous CREST is a member of a chromatin remodeling complex and thereby activates transcription. When expressed in yeast, we found that CREST releases telomeric silencing and causes flocculation. Thus we propose that even in yeast the heterologous CREST protein remodels chromatin causing transcriptional activation of telomerically located genes including those that cause flocculation (e.g. FLO1, FLO5, FLO9 and FLO10) as well as the epigenetically controlled gene FLO11. Likewise, a yeast chromatin remodeling complex protein, SWI1, is required for the expression of telomerically located and epigenetically controlled FLO genes [88] . Interestingly, SWI1
can form infectious prion aggregates [12] reminiscent of the amyloid CREST aggregates seen here.
Our results extend the spectrum of ALS associated proteins that are affected by ATXN2 to include CREST. This supports the hypothesis that therapies that target ATXN2 may be effective for a wide range of neurodegenerative diseases.
Methods
Yeast strains and plasmids
Yeast strains and plasmids used are listed in Tables 1 and 2 . Unless otherwise stated, yeast strain BY4741 (MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0) was used. Yeast transformation was by the lithium acetate method [89] . L3491 bearing an integrated copy of ADH1-HTB1-mCh was used to check CREST nuclear localization [37] . FLO1 (L3580) and FLO11 (L3582) promoter reporter strains were respectively made from DY755 and DY758. DY755 and DY758 are Ura + because FLO8, which is disrupted in these strains, is required for regulation that inhibits the FLO1 and FLO11 promoters [54, 90] . We obtained pop-outs of the HIS3 disruptions of FLO8 by selecting for Urarevertants on 5-FOA plates [91] and checking these for those that had become His -. Several such pop-outs were obtained and tested and they all behaved identically. Unless otherwise stated, all overexpression plasmids were driven by the GAL1 promoter. Gateway technology [92] was used to make CREST entry clone pDONR-CREST with 
Cultivation procedures
Standard media and growth conditions were used [93, 94] . All liquid-culture experiments were carried out with mid-log-phase cells. Complex (YPD) yeast media contained 2% dextrose. Synthetic medium lacked a specific component, e.g. leucine, and contained 2% dextrose, e.g., SD-Leu (-Leu medium) or 2% galactose without (SGal-Leu) or with raffinose 2% (SRGal-Leu). Cells co-transformed with pest, containing hER, were grown in -estradiol (1 M) in glucose media to turn on expression of GAL1 controlled CREST [55] , [56] . FOA medium containing 12 mg/l 5-fluoro-orotic acid and 12 mg/l uracil was used to select for Uracells [91] . To prevent the accumulation of suppressor mutants that reverse CREST toxicity, pGAL1-CREST transformants were maintained on plasmid selective SD medium where CREST was not expressed. Patches were then replica-plated onto synthetic glycerol (2%) to identify petites that were dropped from further study. To analyze growth, non-petite transformants from SD plates were normalized in water to an OD600 of 2 and serially diluted 10X. Finally about 5μl of diluted cell suspensions were spotted on plasmid selective SD, SGal or SD + -estradiol using an MC48 (Dan-kar Corp, MA) spotter.
Western blot analysis
CREST was detected in pre-cleared lysates separated by SDS-Page and blotted as described previously [95] . For analysis of proteins in total lysate vs. supernatant and pellet, the pellet from 90 g of total lysate centrifuged at 50K rpm for 6 min was resuspended in water to the initial volume of total lysate centrifuged. The same sample volumes of total lysate, supernatant and pellet were then separated by SDS-Page. Blots were developed with GFP mouse antibody from Roche Applied Science (Indianapolis, IN) and PGK antibody from life technologies (Frederick, MD).
Visualization of aggregates and co-localization studies
Fluorescently labeled protein aggregates, were visualized in cells with a Nikon Eclipse E600 fluorescent microscope (100X oil immersion) equipped with FITC, YFP and mCh (respectively, chroma 49011, 49003 and 49008) filter cubes. To visualize nuclei, cells with the integrated HTB1-mCh nuclear marker were used [37] .
Flocculation Assay
Flocculation was assayed by resuspending a sample of each 2 d culture grown in plasmid selective SRGal in 50 mM EDTA in water. Since flocculation requires the presence of Ca 2+ ions [96] , the EDTA removed clumping so OD600 of cells could be accurately measured. Then another sample of cells that was not treated with EDTA was appropriately normalized to OD600 =10. Cells were photographed after they were allowed to settle for 15 min. The level of precipitation of cells and the reduction in the OD of the supernatants (diluted 10X) is a measure of the flocculence.
Thioflavin T Staining
Yeast cells were stained with thioflavin T according to a protocol adapted from [31] with the addition of two extra washes in PMST [0.1M KPO4 (pH 7.5), 1 mM MgCl2, 1 M Sorbitol, 0.1% Tween 20].
Generation and characterization of transgenic flies
Generation of human CREST lines used in this study has been described earlier [52] . gmr-GAL4, UAS-lacZ and dAtx2 06490 lines were obtained from the Bloomington Drosophila stock center. Fly stocks were raised on standard Drosophila medium at 20 °C. Crosses between the Drosophila strains were carried out at 25 °C using standard procedures. For histochemical analyses, heads of 5-day-old adult transgenic flies were dissected, collected, briefly washed in phosphate buffered saline (PBS), and fixed with 4% paraformaldehyde containing 0.1% Triton X-100 at room temperature for 2 hours. After a brief wash in PBS, tissues were dehydrated by graded ethanol, cleared in butanol and embedded in paraffin.
Four-micrometer thick coronal sections were stained with hematoxylin and eosin (H&E).
Data Availability
No datasets were generated during the current study. The datasets analyzed during the current study are publically available at https://www.yeastgenome.org/. YCpSUP35NM-GFP, p1181 pRS413-CUP1-SUP35NM-GFP (HIS3) [62] YCp-GAL-GFP, p1764 pAG416-GAL1-ccdB-EGFP (CEN, URA3) Addgene plasmid #14195
YCpGAL-TDP-43-YFP, p2042 pRS416-Gal-TDP-43-YFP (CEN, URA3) Addgene plasmid #27447
YCpGAL-FUS-YFP, p2043 pAG416-GAL1-FUS-YFP (CEN, URA3) This study
YCpGAL-ccdB, p2186 pAG413-GAL-ccdB (CEN, HIS3) Addgene plasmid #14153
YCpGAL-PBP1, p2228 pBY011-GAL1-PBP1 (CEN, URA3) [42] YCpGAL, p2229 pBY011-GAL1 (CEN, URA3) [92] pC1-CREST, p2342 pEGFP-C1-CREST [52] pDONR Cells were then stressed for 20 min at 46°C. CREST-EGFP, DED-mCh and EDC3-mCh were examined before (30°C), during (46°C) and 3 h following (30°C) heat stress. 
